论文部分内容阅读
1996年6月～1998年6月,我们应用基因重组链激酶(r-SK)与尿激酶(UK)静脉溶栓治疗急性心肌梗塞(AMI)70例,现将结果报告如下。 1 资料及方法 1.1 对象选择:①胸痛持续>30分钟,含服硝酸甘油不缓解;②心电图至少两个相邻胸前导联或Ⅱ、Ⅲ、avf中两个导联ST段抬高大于0.1mV;③发病12小时以内;④无溶栓禁忌症。 1.2 一般资料:患者70例,随机分为r-SK组40例及UK组30例,两组情况见表1,两组性别、年龄、梗塞部位以及溶栓距发病时间均无统计学差异,具有可比性。 1.3 给药方法:入选者从入院后立即嚼服阿斯
From June 1996 to June 1998, we treated 70 patients with acute myocardial infarction (AMI) with intravenous thrombolysis with recombinant streptokinase (r-SK) and urokinase (UK). The results are reported below. 1 Materials and Methods 1.1 Object Selection: ① chest pain lasting> 30 minutes, containing nitroglycerin does not ease; ② ECG at least two adjacent chest lead or Ⅱ, Ⅲ, avf ST lead elevation of two leads greater than 0.1 mV; ③ onset within 12 hours; ④ no thrombolytic contraindications. 1.2 General information: 70 patients were randomly divided into 40 cases of r-SK group and 30 cases of UK group, the two groups in Table 1, the two groups of gender, age, location of infarction and the time of onset of thrombolysis was not statistically different, Comparable. 1.3 Method of administration: The candidate chewed as soon after admission